TTS is proud to announce these two metrics reflecting the Transplantation journals continued increase in impact and influence.
This year Transplantation’s impact factor has again risen significantly (from 5.4 to 6.2) at a time when the impact factors of almost all journals in the transplantation field have dropped.
Transplantation Direct has received an Impact Factor for the first time and has jumped in at 2.3, ahead of many established journals in the field, and the highest of the 6 new entrants. This tremendous success is the result of years of hard work and the contributions of many. The Editorial Boards number around 140 people and the reviewer boards represent the global membership of TTS and the Sections.
Led by our Editor-in-Chief Jeremy Chapman and the Executive Editorial Team, Transplantation relies on nine deputy editors spread across the world and nearly one hundred specialist Associate Editors who ensure expert assessment of all submissions.
Edward Geissler leads Transplantation Direct supported by a team of Deputy Editors who come from TTS Sections - ISODP, IPITA and ISUTx - that have adopted Transplantation Direct as their official journal.
These remarkable achievements reflect the excellence and significance of our publications in the field. We congratulate these dedicated teams and thank all our contributors and authors who share their important work globally through the Transplantation journals.
Contribute to the program by submitting your abstract to this year’s SPLIT Annual Meeting. The top three abstracts will receive an award and authors will have the opportunity to give a 10 min oral presentation during the meeting.
Award winners will have the opportunity to present their research in either poster or oral presentation, receive free SPLIT Annual Meeting registration, a grant for reimbursable travel expenses up to $1000 and networking opportunities. We are offering two types of awards
The International Pancreas and Islet Transplant Association (IPITA), the International Xenotransplantation Association (IXA), and the Cell Transplant and Regenerative Medicine Society (CTRMS) reaffirm their strong partnership as leaders in transplantation and promise to provide an outstanding and innovative program.
Leading experts and opinion leaders from all over the world will present the latest data and address important needs in clinical and experimental transplant therapy. Specific sessions will be devoted to hot research in whole-organ pancreas transplantation, islet transplantation, stem cell therapy, xenotransplantation and transplant biology.
We are expecting close to 600 delegates from all over the world.
We look forward to welcoming YOU to San Diego!
Emerging 'Omics' and machine learning techniques: the next frontier in transplant research
|
|||
Translational Immunology Presenter: Juliet Emamaullee, United States |
|||
Cite sequencing Presenter: Sören Lukassen, Germany |
|||
Single cell sequencing and spatial transcriptomics in kidney disease Presenter: Parker C. Wilson, United States |
|||
Spatial proteomics Presenter: Roman Fischer, United Kingdom |
|||
Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunity Presenter: Ana Konvalinka, Canada |
|||
|
Dear Colleagues,
With the conclusion of the 18th Congress of the Middle East Society for Organ Transplantation (MESOT 2023) that took place on May 24-26, 2023, I would like to express my sincere appreciation for those who attended and contributied at the meeting.
From its inception, the goals of MESOT have been to encourage the development of scientifically and ethically superior organ transplantation activities across the globe. Therefore, The MESOT International Congress is the major international transplant congress and attracts a broad range of health professionals.
MESOT 2023 Congress which was endorsed by The Transplantation Society (TTS), The Turkish Transplantation Society (TOND) and The Turkic World Transplantation Society (TDTD) proved to be a great success, with high positive feedback from all who were in attendance. The total number of registrations for the MESOT Congress was 320 from 38 countries. A total of 55 Invited Lectures, 38 Oral and 116 Poster Presentations were scheduled for the congress.
The scientific program incorporated a wide range of topics designed to provide an innovative and comprehensive overview of the latest developments in the field of experimental and clinical transplantation in the Middle East and the world. I hope it has provided valuable insights for our colleagues in the transplant field across the globe.
Once again, thank you for your support it was an honor to host this important Congress.
Sincerely,
Mehmet Haberal, MD, FACS (Hon), FICS (Hon),
FASA (Hon), FIMSA (Hon), Hon FRCS (Glasg)
Founder and Past-President, MESOT
Congress Chair, 18th Congress of the Middle East Society for Organ Transplantation
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada